Suppr超能文献

恶性肿瘤的克隆性(综述)

Clonality of malignant-tumors (review).

作者信息

Chigira M, Watanabe H

出版信息

Oncol Rep. 1994 Jan;1(1):79-81.

Abstract

Heterogeneous descendants are continuously produced in tumor cell evolution, although the first step of carcinogenesis may involve a single clone. From the data obtained by molecular biology, we have to recognize that the 'clonality of tumor' proliferated from a single clone does not confirm the genetic identity of tumor cell society. The so-called 'multi-hit hypothesis' can not explain this heterogeneity, since this hypothesis only describes serial changes of genes in carcinogenesis. However, genetic alterations actually accumulate progressively after carcinogenesis until the end of total cell death. Genetic alterations in tumor evolution are a stochastic process rather than a non-stochastic one, since 'neutral evolution' in molecules occurs in micro-environments, It is an essential concept that retrospective analysis can never demonstrate the clonal origin of tumors, because the genetic pool of tumor cell society is unstable and changes proliferation-dependently.

摘要

在肿瘤细胞进化过程中会持续产生异质性后代,尽管致癌作用的第一步可能涉及单个克隆。从分子生物学获得的数据来看,我们必须认识到,从单个克隆增殖而来的“肿瘤克隆性”并不能证实肿瘤细胞群体的基因一致性。所谓的“多击假说”无法解释这种异质性,因为该假说仅描述了致癌过程中基因的系列变化。然而,致癌作用发生后,基因改变实际上会逐渐积累,直至所有细胞死亡结束。肿瘤进化中的基因改变是一个随机过程而非非随机过程,因为分子中的“中性进化”发生在微环境中。回顾性分析永远无法证明肿瘤的克隆起源,这是一个至关重要的概念,因为肿瘤细胞群体的基因库不稳定且会随增殖而变化。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验